A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Safety and Efficacy of ES135 in Subjects With Spinal Cord Injury

Summary

To demonstrate the superior effect of ES135 combined with spinal cord repairing surgery, compared to a placebo control with spinal cord repairing surgery, on post-surgery motor function recovery as measured by the changes from baseline of ISNCSCI Motor Scores in subjects

Timeline

Start

2018-03-07

Primary completion

2024-12-31

Completion

2026-12-31

Outcome

Outcome not reported

Stopped (Enrollment): “low recruitment rate”

Drugs

Indications